Company Overview

Zygogen, LLC provides zebrafish research products and services for academic and commercial applications. Its products include zebrafish embryos, including Z-Tag fluorescent blood vessel embryos, Z-Tag fluorescent heart embryos, Z-Tag fluorescent neuron embryos, Z-Tag fluorescent thrombocyte embryos, wild-type embryos, and morphant gene knockdown embryos. The company’s products also include assay starter kits, such as Z-Tag acute toxicity assay and Z-Tag cardio-toxicity assay starter kits. In addition, it offers compound screening services, such as angiogenesis assays, acute toxicity assays, cardio-toxicity analysis, notch activity analysis, cartilage assessment, bone assessment, and morpholo...

Zygogen, LLC provides zebrafish research products and services for academic and commercial applications. Its products include zebrafish embryos, including Z-Tag fluorescent blood vessel embryos, Z-Tag fluorescent heart embryos, Z-Tag fluorescent neuron embryos, Z-Tag fluorescent thrombocyte embryos, wild-type embryos, and morphant gene knockdown embryos. The company’s products also include assay starter kits, such as Z-Tag acute toxicity assay and Z-Tag cardio-toxicity assay starter kits. In addition, it offers compound screening services, such as angiogenesis assays, acute toxicity assays, cardio-toxicity analysis, notch activity analysis, cartilage assessment, bone assessment, and morphological analysis. Further, the company provides gene analysis services, including RT-PCR expression analysis and gene knockdown services. Zygogen, LLC was founded in 1999 and is based in Atlanta, Georgia. On April 30, 2009, Zygogen, LLC filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Georgia, Atlanta.

Key Executives for Zygogen, LLC

Similar Private Companies By Industry

Recent Private Companies Transactions